Clinical trials
Phase 1 Hereditary Sensory and Autonomic Neuropathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 8 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Genentech, Inc. | 2 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2 |
| AbbVie | 1 |
| Anwaar Saeed | 1 |
| Asana BioSciences | 1 |
| Bayer | 1 |
| Cascadian Therapeutics Inc. | 1 |
| Celcuity Inc | 1 |
| Chipscreen Biosciences, Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hereditary Sensory and Autonomic Neuropathies | 30 |
| Breast Neoplasms | 5 |
| Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Ovarian Neoplasms | 3 |
| Colorectal Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Lymphoma | 2 |
| Melanoma | 2 |
Trials
Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.